Cargando…

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

BACKGROUND: Heterogeneity and lack of targeted therapies represent the two main impediments to precision treatment of triple-negative breast cancer (TNBC), and therefore, molecular subtyping and identification of therapeutic pathways are required to optimize medical care. The aim of the present stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jézéquel, Pascal, Kerdraon, Olivier, Hondermarck, Hubert, Guérin-Charbonnel, Catherine, Lasla, Hamza, Gouraud, Wilfried, Canon, Jean-Luc, Gombos, Andrea, Dalenc, Florence, Delaloge, Suzette, Lemonnier, Jérôme, Loussouarn, Delphine, Verrièle, Véronique, Campone, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525459/ https://www.ncbi.nlm.nih.gov/pubmed/31101122 http://dx.doi.org/10.1186/s13058-019-1148-6

Ejemplares similares

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
por: Jézéquel, Pascal, et al.
Publicado: (2015)

Gene-expression signature functional annotation of breast cancer tumours in function of age
por: Jézéquel, Pascal, et al.
Publicado: (2015)

bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses
por: Jézéquel, Pascal, et al.
Publicado: (2021)

Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
por: Basseville, Agnes, et al.
Publicado: (2022)

bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses
por: Jézéquel, Pascal, et al.
Publicado: (2013)

Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
por: Loussouarn, D, et al.
Publicado: (2009)

STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
por: Lohard, Steven, et al.
Publicado: (2020)

c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1
por: Campone, Mario, et al.
Publicado: (2011)

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
por: Dagher, Elie, et al.
Publicado: (2019)

Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers
por: Louault, K., et al.
Publicado: (2019)

Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study
por: Dagher, Elie, et al.
Publicado: (2019)

Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
por: Guillon, Jordan, et al.
Publicado: (2019)

Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [(18)F]FDG PET/CT in Early Triple-Negative Breast Cancer
por: Bouron, Clément, et al.
Publicado: (2022)

Logic programming reveals alteration of key transcription factors in multiple myeloma
por: Miannay, Bertrand, et al.
Publicado: (2017)

γ-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells
por: Séveno, Céline, et al.
Publicado: (2012)

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
por: Darlix, Amélie, et al.
Publicado: (2019)

The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study
por: Jaillardon, Laetitia, et al.
Publicado: (2015)

YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network
por: Véquaud, Eloïse, et al.
Publicado: (2015)

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
por: Sarradin, Victor, et al.
Publicado: (2021)

Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
por: Grinda, Thomas, et al.
Publicado: (2021)

Tumor cell malignancy: A complex trait built through reciprocal interactions between tumors and tissue-body system
por: Feunteun, Jean, et al.
Publicado: (2022)

Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
por: Nguyen, Frédérique, et al.
Publicado: (2017)

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1
por: Berger, Frédérique, et al.
Publicado: (2022)

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study
por: Bidard, François-Clément, et al.
Publicado: (2012)

Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme
por: Cartron, P F, et al.
Publicado: (2012)

Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program
por: Cabel, Luc, et al.
Publicado: (2021)

Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer
por: Domergue, Camille, et al.
Publicado: (2022)

Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up
por: Veron, Lucie, et al.
Publicado: (2021)

Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance
por: Abadie, Jérôme, et al.
Publicado: (2017)

Comment on ‘How the evolution of multicellularity set the stage for cancer’
por: Jézéquel, Pascal, et al.
Publicado: (2018)

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis
por: Carey, Lisa A., et al.
Publicado: (2022)

Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
por: Billaud, Amandine, et al.
Publicado: (2020)

miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells
por: Das, Sonia G., et al.
Publicado: (2016)

The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID‐19?
por: Hondermarck, Hubert, et al.
Publicado: (2020)

The nervous system: Orchestra conductor in cancer, regeneration, inflammation and immunity
por: Hondermarck, Hubert, et al.
Publicado: (2021)

Neural regulation of body polarities in nereid worm regeneration
por: Boilly, Benoni, et al.
Publicado: (2022)

Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients
por: Moreau-Bachelard, Camille, et al.
Publicado: (2020)

Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy
por: Winter, Marie, et al.
Publicado: (2023)

Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study
por: Alhenc-Gelas, Marion, et al.
Publicado: (2021)

Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort
por: Antoine, Alison, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j60edqqeku6j56irs0jfnu29u6